https://www.selleckchem.com/pe....ptide/lypressin-acet
5% CI .83 - 1.43, P=.57). CONCLUSIONS Patients with HIV/AIDS undergoing AV access creation have similar outcomes to those without HIV, including long-term survival. Patients with HIV/AIDS had fewer traditional ESRD risk factors compared to non-HIV patients. Our findings show that contemporary approach for creation and management of AV access in patients with HIV/AIDS should be continued, however, further research is needed to identify risk factors in this population. BACKGROUND Contrast induced nephropathy is a possible adverse
Like
Comment
Share
